Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vermillion Inc (VRML)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,753
  • Shares Outstanding, K 75,270
  • Annual Sales, $ 3,120 K
  • Annual Income, $ -10,500 K
  • 36-Month Beta 1.07
  • Price/Sales 12.66
  • Price/Cash Flow N/A
  • Price/Book 3.05
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.20
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/15
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +908,281.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.47 +5.28%
on 10/19/18
0.77 -35.05%
on 09/25/18
-0.21 (-29.56%)
since 09/21/18
3-Month
0.47 +6.40%
on 08/15/18
0.77 -35.05%
on 09/25/18
-0.15 (-23.06%)
since 07/20/18
52-Week
0.47 +6.40%
on 08/15/18
2.10 -76.19%
on 12/18/17
-0.99 (-66.44%)
since 10/20/17

Most Recent Stories

More News
Vermillion, Inc. Announces the Launch of OVA1(R)+

The new best-in-class reflex offering combines strengths from OVA1 and OVERA

VRML : 0.51 (+8.51%)
Vermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell

Vermillion, Inc. (NASDAQ:VRML), a bioanalytical-based women's health company focused on gynecologic disease, will ring the NASDAQ closing bell today.

VRML : 0.51 (+8.51%)
Vermillion, Inc. Appoints Nancy Cocozza to its Board of Directors

Seasoned managed care leader with 30+ years of managed health experience

VRML : 0.51 (+8.51%)
Vermillion: 2Q Earnings Snapshot

AUSTIN, Texas (AP) _ Vermillion Inc. (VRML) on Thursday reported a loss of $3 million in its second quarter.

VRML : 0.51 (+8.51%)
Vermillion Reports Second Quarter 2018 Financial Results

Conference Call scheduled for today, August 9, 2018 at 4:30 p.m. ET

VRML : 0.51 (+8.51%)
Vermillion to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Thursday, August 9

Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it will report financial results for the second quarter and six months ended June...

VRML : 0.51 (+8.51%)
Vermillion, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Vermillion, Inc. (NASDAQ: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 4:30 PM Eastern Time.

VRML : 0.51 (+8.51%)
Vermillion: 1Q Earnings Snapshot

AUSTIN, Texas (AP) _ Vermillion Inc. (VRML) on Monday reported a loss of $2.9 million in its first quarter.

VRML : 0.51 (+8.51%)
Vermillion Reports First Quarter 2017 Financial Results

Conference Call scheduled for today, May 14 at 4:30 p.m. ET

VRML : 0.51 (+8.51%)
Vermillion to Report First Quarter 2018 Financial Results on Monday, May 14

Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its first quarter ended March 31, 2018 financial results on Monday,...

VRML : 0.51 (+8.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade VRML with:

Business Summary

Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide...

See More

Key Turning Points

2nd Resistance Point 0.55
1st Resistance Point 0.51
Last Price 0.51
1st Support Level 0.46
2nd Support Level 0.44

See More

52-Week High 2.10
Fibonacci 61.8% 1.48
Fibonacci 50% 1.28
Fibonacci 38.2% 1.09
Last Price 0.51
52-Week Low 0.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar